Platelet-Endothelium Interactions

New England Journal of Medicine

Volumn 328, Issue 9, 1993, Pages 628-635

  Flier, Jeffrey S ^a   Underhill, Lisa H ^a   Ware, J Anthony ^b   Heistad, Donald D ^c  

^a Harvard Medical School ^*

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ENDOTHELIUM DERIVED RELAXING FACTOR; PROSTACYCLIN; SEROTONIN; SEROTONIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOMODULIN; THROMBOXANE A2; NITRIC OXIDE;

ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; CELL INTERACTION; DIABETES MELLITUS; EXPERIMENTAL MODEL; HYPERTENSION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; VASCULAR ENDOTHELIUM; VASCULAR SURGERY; ARTERIOSCLEROSIS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ADHESIVENESS;

ARTERIOSCLEROSIS; BLOOD PLATELETS; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMAN; HYPERTENSION; NITRIC OXIDE; PLATELET ADHESIVENESS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027397638     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199303043280907     Document Type: Review

References (79)

1. Marcus AJ Review: Stratton Lecture 1989: thrombosis and inflammation as multicellular processes: patho-physiologic significance of transcellular metabolism. Blood 1990; 76:1903-1907
2. Curwen KD, Gimbrone MA Jr, Handin RI In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Lab Invest 1980; 42:366-374
3. Osborn L Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62:3-6
4. Albelda SM, Muller WA, Buck CA, Newman PJ Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 1991; 114:1059-1068
5. Lawrence MB, Springer TA Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65:859-873
6. Hamburger SA, McEver RP GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75:550-554
7. 2, and adenine nucleotides. J Clin Invest 1986; 78:539-544
8. Schafer AI, Crawford DD, Gimbrone MA Jr Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. J Clin Invest 1984; 73:1105-1112
9. Kent KC, Collins LJ, Schwerin FT, Raychowdhury MK, Ware JA. Identification of functional PGH/TxA receptors on human endothelial cells. Circ Res (in press).
10. Romano M, Serhan CN Lipoxin generation by permeabilized human platelets. Biochemistry 1992; 31:8269-8277
11. Furchgott RF, Zawadzki JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376
12. Moncada S, Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142
13. Nguyen BL, Saitoh M, Ware JA Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991; 261: H1043-H1052
14. Durante W, Kroll MH, Vanhoutte PM, Schafer AI Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992; 79:110-116
15. Hibbs JB Jr, Westenfelder C, Taintor R, Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89:867-877
16. Nolte C, Eigenthaler M, Schanzenbacher P, Walter U Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. J Biol Chem 1991; 266:14808-14812
17. Bowen R, Haslam RJ Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood: role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. J Cardiovasc Pharmacol 1991; 17:424-433
18. Adams DJ, Barakeh J, Laskey R, Van Breemen C Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989; 3:2389-2400
19. Coller BS Platelets and thrombolytic therapy. N Engl J Med 1990; 322:33-42
20. Penny WF, Ware JA Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator. Blood 1992; 79:91-98
21. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. Blood 1985; 65:32-40
22. Loscalzo J, Vaughan DE Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest 1987; 79:1749-1755
23. Dittman WA, Majerus PW Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990; 75:329-336
24. Yao SK, Ober JC, McNatt J, ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res 1992; 70:39-48
25. Marcus AJ, Safier LB, Hajjar KA, Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase: thromboregulation by endothelial cells. J Clin Invest 1991; 88:1690-1696
26. 2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine: study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 1987; 79:600-608
27. Penny WF, Weinstein MJ, Salzman EW, Ware JA Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation 1991; 83:1630-1636
28. Yanagisawa M, Kurihara H, Kimura S, A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415
29. Webb DJ Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed. Trends Pharmacol Sci 1991; 12:43-46
30. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325:997-1001
31. Saito Y, Nakao K, Mukoyama M, Imura H Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322:205-205
32. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T Plasma endothelin levels in patients with uraemia. Lancet 1989; 1:991-992
33. Prescott SM, Zimmerman GA, McIntyre TM Platelet-activating factor. J Biol Chem 1990; 265:17381-17384
34. Meade CJ, Heuer H, Kempe R Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia. Biochem Pharmacol 1991; 41:657-668
35. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DGL Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 1986; 58:783-789
36. Yamamoto H, Bossaller C, Cartwright J Jr, Henry PD Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest 1988; 81:1752-1758
37. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990; 344:160-162
38. Ludmer PL, Selwyn AP, Shook TL, Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315:1046-1051
39. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 1984; 54:711-718
40. Golino P, Piscione F, Willerson JT, Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991; 324:641-648
41. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991; 324:648-654
42. Williams JK, Baumbach GL, Armstrong ML, Heistad DD Hypothesis: vasoconstriction contributes to amaurosis fugax. J Cereb Blood Flow Metab 1989; 9:111-116
43. Folts JD, Gallagher K, Rowe GG Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 1982; 65:248-255
44. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation 1989; 80:198-205
45. Yao SK, Benedict CR, Rosolowsky M, Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis. J Mol Cell Cardiol 1991; 23:473-482
46. Willerson JT, Yao SK, McNatt J, Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci U S A 1991; 88:10624-10628
47. FitzGerald GA, Smith B, Pedersen AK, Brash AR Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 1984; 310:1065-1068
48. Vallance P, Leone A, Calver A, Collier J, Moncada S Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575
49. Sarrell PM, Lindsay DC, Poole-Wilson PA, Collins P Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet 1990; 336:1030-1032
50. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27
51. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320:1025-1030
52. Tesfamariam B, Brown ML, Cohen RA Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991; 87:1643-1648
53. Erne P, Bolli P, Burgisser E, Buhler FR Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med 1984; 310:1084-1088
54. 2+ in platelets from patients with uremia. Blood 1989; 73:172-176
55. Kaul S, Waack BJ, Brooks RM, Heistad DD Altered vascular responses to platelets from hypercholesterolemic humans. Stroke 1992; 23:153-153 abstract.
56. Kent KC, Mii S, Voronof SB, Leone PV, Ware JA Protein kinase C and protein phosphatases in endothelial cell proliferation. Circulation 1992; 86: Suppl I: I-289 abstract.
57. Cunningham LD, Brecher P, Cohen RA Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta. J Clin Invest 1992; 89:878-882
58. Mannucci PM Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72:1449-1455
59. Johnstone MT, Andrews T, Ware JA, Bleeding time prolongation with streptokinase and its reduction with 1-desamino-8-D-arginine vasopressin. Circulation 1990; 82:2142-2151
60. Vane JR, Anggard EE, Botting RM Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36
61. Pedersen AK, FitzGerald GA Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984; 311:1206-1211
62. Brezinski DA, Nesto RW, Serhan CN Angioplasty triggers intracoronary leukotrienes and lipoxin A: impact of aspirin therapy. Circulation 1992; 86:56-63
63. Williams JK, Adams MR, Klopfenstein HS Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81:1680-1687
64. Harrison DG, Armstrong ML, Freiman PC, Heistad DD Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80:1808-1811
65. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990; 67:1301-1308
66. Drexler H, Zeiher AM, Meinzer K, Just H Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338:1546-1550
67. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 1991; 69:1293-1300
68. Petros A, Bennett D, Vallance P Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
69. Reis GJ, Pasternak RC Fish oil and restenosis rates. Lancet 1989; 2:1036-1036
70. Chang JD, Ware JA Molecular genetic analysis of protein kinase C (PKC) isoenzyme distribution in human platelets. Clin Res 1992; 40:225A-225A abstract.
71. Shanker R, de la Motte CA, DiCorieto PE Thrombin stimulates PDGF production and monocyte adhesion through distinct intracellular pathways in human endothelial cells. Am J Physiol 1992; 262: C199-C206
72. Wilson JM, Birinyi LK, Salomon RN, Libby P, Callow AD, Mulligan RC Implantation of vascular grafts lined with genetically modified endothelial cells. Science 1989; 244:1344-1346
73. Nabel EG, Plautz G, Nabel GJ Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249:1285-1288
74. Housey GM, Johnson MD, Hsiao WL, Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 1988; 52:343-354
75. Borner C, Filipuzzi I, Weinstein IB, Imber R Failure of wild-type or a mutant form of protein kinase C-alpha to transform fibroblasts. Nature 1991; 353:78-80
76. Hashemi S, Tackaberry ES, Palmer DS, Rock G, Ganz PR DDAVP-induced release of von Willebrand factor from endothelial cells in vitro: the effect of plasma and blood cells. Biochim Biophys Acta 1990; 1052:63-70
77. Serhan CN, Sheppard K-A Lipoxin formation during human neutrophil-platelet interactions: evidence for the transformation of leukotriene A by platelet 12-lipoxygenase in vitro. J Clin Invest 1990; 85:772-780
78. Fiore S, Serhan CN Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 1990; 172:1451-1457
79. Dorn GW II, Liel N, Trask JL, Mais DE, Assey ME, Halushka PV Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation 1990; 81:212-218